Bio-Rad Laboratories, Inc. (BIO) Average EV/EBITDA Ratio
The current ev/ebitda ratio for Bio-Rad Laboratories, Inc. (BIO) is 262.68x as of Tuesday, June 9, 2026, shown against its trailing averages.
Average EV/EBITDA Ratio Chart
BIO EV/EBITDA Ratio Averages
EV/EBITDA RATIO CURRENT
262.68x
EV/EBITDA RATIO TTM
52.45x
EV/EBITDA RATIO 3Y
101.26x
EV/EBITDA RATIO 5Y
61.74x
EV/EBITDA RATIO 10Y
38.62x
EV/EBITDA RATIO 15Y
29.18x
EV/EBITDA RATIO 20Y
24.43x
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz